Physician

David Ober Magnante, MD

According to 2025 Medicare claims, David Magnante, MD (NPI: 1255309423) practices ophthalmology in the Lafayette-West Lafayette, IN market, with the plurality of this provider's patient population coming from Tippecanoe, IN. This provider's primary affiliated billing organization is MAGNANTE EYE CARE II LLC (NPI: 1548966054; TIN: 921611256) and primary practice location at 47905-8635. Magnante is affiliated with the Imperium Clinical Partners (ACO ID: A4945), participating under the MSSP model.

Magnante's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 546 traditional Medicare patients, billed 3,406 HCPCS/CPT codes, and received $521,648 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,332 prescription claims across 417 beneficiaries totaling $47,457 in drug costs, led by Xiidra (Lifitegrast). 2015 DME data shows 52 claims. Open Payments data shows 16 records totaling $291. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $434,363 and ending at $521,648. Concurrently, Part D prescription costs have fallen sharply in recent years, from $167,111 to $47,457. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.